[Company Performance]: Financial results like revenue, profit margins, and earnings per share significantly impact investor confidence.

[Industry Trends]: Growth or decline in the pharmaceutical sector, regulatory changes, and competition affect stock valuation.

[Market Sentiment]: Overall investor mood, economic outlook, and global events influence buying and selling pressure.

[Regulatory Approvals]: Success or failure in obtaining regulatory approvals for new drugs affects future revenue potential.

[Raw Material Prices]: Fluctuations in the cost of raw materials used in drug manufacturing impact profit margins.

[Currency Fluctuations]: Exchange rate changes can affect the revenue and profitability of the company, especially with exports.

[Competition]: Competitive landscape, including new entrants and pricing strategies, influences market share and profitability.

[Research and Development]: Investment in R&D and the success of new product development determine future growth prospects.

[Management Decisions]: Strategic decisions made by the company's management team, such as acquisitions and expansions.